SEC Form 4 · accession 0000899243-16-012689
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark W Frohlich
Officer — See Remarks
Period of report
Feb 2, 2016
Accepted (ET)
Feb 4, 2016 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $24.50 | Feb 2, 2016 | A | 55,000 | A | — | Feb 1, 2026 | Common Stock | 55,000 | 55,000 | D |
Explanation of responses
- F11/48 of the shares subject to the option become vested and exercisable on March 2, 2016 and 1/48 of the shares subject to the option shall vest monthly thereafter.
Remarks
Executive Vice President, Development & Portfolio Strategy